Chromosome fragility in two families not exhibiting amplification of the CGG trinucleotide associated with the fragile X site has been examined. Fluorescence in situ hybridisation with cosmid DNA from loci immediately flanking FRAXA and other distal loci have confirmed that cytogenetic fragility in these subjects is the result of expression of a new folate sensitive fragile X site, FRAXE.
Expression of the fragile site was induced in peripheral blood lymphocytes using folate depleted culture medium and chromosome spreads were prepared by standard techniques.
The folate sensitivity of the fragile site in family 1 was assessed by culturing lymphocytes from III21 in folic acid depleted medium without serum (FX-1 Biological Industries) and comparing the frequency of fragile sites with the frequency found when folic acid (Sigma) at a final concentration of 1 mg/ml was added for the last 24 hours to a parallel culture in the same medium.2' Slides from these cultures, other parallel cultures from the same subject, and a fragile X negative control were coded and scored blind. A repeat blood sample could not be obtained from subject 12 of family 2, so folate sensitivity was assessed by using a lymphoblastoid cell line established from III1. Cultures were incubated for 48 hours in FX-1 medium with 5% serum. The fragile site was induced by adding FUdR (Sigma) at a final concentration of 10-' mol/l for the last 24 hours of culture22 and the effect on expression was examined in parallel cultures where folic acid was added at a final concentration of 1 mg/ml in addition to the FUdR. The slides were coded and scored blind.
PROBES
Cosmids corresponding to the loci G9L (G9LB, ICRFc104D08104), 141R The location of chromosome fragility in Xq27 was examined by fluorescent in situ hybridisation using cosmids flanking FRAXA (fig 1) . Five fragile X site positive subjects exhibiting the typical CGG amplification pattern associated with the fragile X syndrome and the two fragile X site positive subjects showing no such amplification were examined. The results are listed in the table. In the five subjects with FRAXA, G9L lies proximal and 141R distal to the site of chromosome fragility. As can be seen, the locus 141R was found to lie proximal to the position of fragility in patients III21 and 12, indicating that the fragile site in these subjects was not FRAXA.
To define the distal limit of fragility in these two subjects, chromosomes were examined with a cosmid for the locus VK21. As can be seen from the who are clinically normal. In family 2 a fragile X positive male failed to transmit the fragile site to his daughter who is phenotypically normal but the fragile site reappears in the grandson who presents with learning difficulties. This is an unusual situation, as normal transmitting males are usually fragile X negative. In both these families the site of chromosome fragility is not at FRAXA, but at a more distal locus, FRAXE, which has been shown in both families to be folate sensitive. The FRAXE site was first reported by Sutherland and Baker'9 in a family with three fragile X positive brothers. In that family, only one of the sibs was mentally impaired, suggesting that fragile site expression and mental impairment are not associated and this may be the case in the two families reported here.
Two other families have been reported where a folate sensitive fragile site shows no association with mental retardation.' Within the Voelckel pedigree45 the fragile X positive male was mentally normal and the fragile site failed to be transmitted from father to daughter in the single observed case. This is similar to the observation in family 2, where fragility then reappears in the grandson. In the Voelckel case45 the grandson was not tested for fragility. Other fragile site positive families lacking the CGG trinucleotide amplification may be expressing a FRAXE site, and the nature of the fragile site in these families can now be readily determined by FISH. At present it is unclear whether FRAXE carries any phenotypic effects; it is possible that its association with mentally impaired subjects and families could be because of ascertainment bias, although pedigree analysis in family 1 would suggest X linkage. As more FRAXE subjects are characterised, any relationship with mental impairment will be clarified. It is known, however, that the expression of FRAXA can have an effect on the expression of the Hunter gene.30 What effect, if any, the expression of FRAXE may have upon FMR-1, MRX3,31 or other genes in the region is as yet unknown. The expression of the FMR-1 gene in lymphoblastoid cell lines of our two families appears normal (unpublished data). A detailed map of the FRAXE region is now needed to determine whether any DNA abnormality exists at or around the FRAXE site. Our earlier mapping showed the presence of an HTF island within the FRAXE region,8 which does raise the possibility of another gene in this area associated with a mild form of X linked mental retardation.
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